For companies that sell into public healthcare
RGS works with generics and biosimilar manufacturers, manufacturers that sell through licensing partners, branded pharmaceutical companies and medtech suppliers. What they share: volume decided in public tenders, and the need to see results, prices and the companies behind them.
See the results of the tenders that decide your volume
For generics and biosimilar companies, tenders decide a large share of European volume. RGS shows the relevant rounds across Europe, who holds each contract today, what has won before, and the...
For generics and biosimilars Branded pharmaSee where your brand is bought, priced and challenged
Hospital tenders publish what buyers pay for branded medicines and when competitors arrive. RGS turns that into a market access view: who buys your brand, at what price, when generics or...
For branded pharma MedTechMedical device tenders across Europe
Medical devices, diagnostics and consumables are bought through hospital and central purchasing tenders across Europe. RGS finds the tenders that fit your range, shows who wins them and at what...
For medtech Partner-led manufacturersYour partners hold the authorisations. You still need to see the market
Manufacturers that out-license or supply through partners rarely see the tenders, registrations or supplier choices that decide their volume. RGS brings these into view: which tenders your...
For partner-led manufacturersNot sure which fits you?
Tell us how you sell, directly or through partners, and we will show you the view that matches.